Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Evaluation of Diagnostic Performance of [18F]FPSMA-1007 PET/CT in Patients With Suspected Prostate Cancer

NCT05422105 is registered in ClinicalTrials.gov with Primo Biotechnology Co., Ltd as lead sponsor.

NCT NCT05422105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05422105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Evaluation of Diagnostic Performance of [18F]FPSMA-1007 PET/CT in Patients With Suspected Prostate Cancer
Lead sponsor
Primo Biotechnology Co., Ltd
Phase
Observational
Overall status
Suspended
Start date
July 1, 2023
Completion date
December 31, 2026
Enrollment
230 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostate neoplasm